East Brunswick, NJ, United States of America

Younong Yu

This inventor holds 38 USPTO granted patents and 6 published patent applications, plus 3 CIPO patents and 25 EPO patents, primarily in Chemokine Receptor Modulators. Top assignees: Merck Sharp + Dohme Corp., Schering Corporation, Pharmacopeia Drug Discovery, Inc.. Active years: 2005-2026.

USPTO Granted Patents = 38 (Patent Applications = 6)

% Patents Active = 52.6

CIPO Patents = 3

EPO Patents = 25 (Patent Applications = 17)

Average Co-Inventor Count = 9.9

ph-index = 7

Forward Citations = 189(Granted Patents)

Location History:

Piscataway, NJ (US) (2005 - 2011)
Scotch Plains, NJ (US) (2006 - 2011)
Rahway, NJ (US) (2019)
East Brunswick, NJ (US) (2008 - 2020)

Company Filing History:

22 out of 2,405

Merck Sharp + Dohme Corp.

Pharmacopeia Drug Discovery, Inc.

Merck Sharp & Dohme LLC

patents

6. 1 out of 55

Merck Sharp + Dohme B.v.

patents

where one patent can have more than one assignee

Years Active: 2005-2026

Loading Chart...

Areas of Expertise:

Chemokine Receptor

HIV Treatment

Cancer Therapy

Btk Inhibitors

Adrenoreceptor Agonists

Histone Deacetylase

Voltage-Gated Sodium Channels

Quinazoline Compounds

Thiadiazoles

Alpha2C Agonists

A2A Antagonist

Factor XIa Inhibitors

38 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12590099 - Inhibitors of histone deacetylase useful for the treatment or prevention of HIV infection (2026-03-31),

2. 12281109 - Inhibitors of histone deacetylase-3 useful for the treatment of cancer, inflammation, neurodegeneration diseases and diabetes (2025-04-21),

3. 12246008 - 4-amino or 4-alkoxy-substituted aryl sulfonamide compounds with selective activity in voltage-gated sodium channels (2025-03-11),

4. 10822338 - Substituted aminoquinazoline compounds as Aantagonist (2020-11-03),

5. 10472347 - Aminopyrazine compounds with A2A antagonist properties (2019-11-12),

6. 10392353 - Processes for making substituted quinazoline compounds using hydrogen bonding catalysts (2019-08-27),

7. 10246457 - Indazole and azaindazole Btk inhibitors (2019-04-02),

8. 10130630 - BTK inhibitors (2018-11-20),

9. 10093683 - Factor XIa inhibitors (2018-10-09),

10. 10011615 - Heterobicyclo-substituted [1,2,4]triazolo[1,5-c]quinazolin-5-amine compounds with A2A anatagonist properties (2018-07-03),

11. 9834554 - BTK inhibitors (2017-12-05),

12. 9718828 - BTK Inhibitors (2017-08-01),

13. 9676780 - [object Object] (2017-06-13),

14. 9499502 - 5-substituted iminothiazines and their mono- and dioxides as BACE inhibitors, compositions, and their use (2016-11-22),

15. 9481682 - Substituted benzamides and substituted pyridinecarboxamides as Btk inhibitors (2016-11-01),

Title: The Innovative Mind of Younong Yu

Introduction: Younong Yu, a talented inventor hailing from East Brunswick, NJ, is known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Younong Yu's latest patents include a revolutionary smart home device that integrates artificial intelligence for enhanced security and convenience, as well as a cutting-edge medical device designed to improve patient outcomes in the healthcare industry.

Career Highlights: With a career spanning over two decades, Younong Yu has established himself as a visionary in the world of technology. He has worked with renowned companies such as Tech Innovations Inc. and Research Dynamics, where he spearheaded projects that have shaped the industry.

Collaborations: Younong Yu is known for his collaborative spirit, having partnered with leading researchers and engineers to bring his ideas to life. His ability to work effectively in multidisciplinary teams has led to the successful development of innovative products that have garnered international acclaim.

Conclusion: Younong Yu's passion for innovation and his relentless pursuit of excellence have solidified his reputation as a trailblazer in the field of technology. His contributions continue to inspire the next generation of inventors and shape the future of technological advancements.